These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 5546190
1. Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cells. Wepsic HT, Bernstein ID, Zbar B, Borsos T, Rapp HJ. J Natl Cancer Inst; 1971 Jan; 46(1):195-202. PubMed ID: 5546190 [No Abstract] [Full Text] [Related]
2. In vivo methods for the assessment of cell-mediated tumor immunity. Bartlett GL. Natl Cancer Inst Monogr; 1972 Dec; 35():27-32. PubMed ID: 4659049 [No Abstract] [Full Text] [Related]
3. [Studies on immunogenicity of the soluble tumor antigen obtained from transplantable tumor cells of guinea pigs (author's transl)]. Ueda N. Nihon Hifuka Gakkai Zasshi; 1978 May; 88(6):399-409. PubMed ID: 307625 [No Abstract] [Full Text] [Related]
4. Tumor-specific antigens: detection by local transfer of delayed skin hypersensitivity. Kronman BS, Rapp HJ, Borsos T. J Natl Cancer Inst; 1969 Oct; 43(4):869-75. PubMed ID: 4310097 [No Abstract] [Full Text] [Related]
7. Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy. Bartlett GL, Zbar B. J Natl Cancer Inst; 1972 Jun; 48(6):1709-26. PubMed ID: 4341405 [No Abstract] [Full Text] [Related]
8. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin. Zbar B, Bernstein ID, Rapp HJ. J Natl Cancer Inst; 1971 Apr; 46(4):831-9. PubMed ID: 4324814 [No Abstract] [Full Text] [Related]
9. Systemic transfer of tumor immunity: delayed hypersensitivity and suppression of tumor growth. Wepsic HT, Zbar B, Rapp HJ, Borsos T. J Natl Cancer Inst; 1970 Apr; 44(4):955-63. PubMed ID: 11515063 [No Abstract] [Full Text] [Related]
10. [Variations of cellular type specific immunological defense mechanisms as a function of tumor growth]. Barski G, Youn JK, Belehradek J, Le François D. Ann Inst Pasteur (Paris); 1972 Apr; 122(4):633-43. PubMed ID: 5050873 [No Abstract] [Full Text] [Related]
11. Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells. Nagai A, Zbar B, Terata N, Hovis J. Cancer Res; 1983 Dec; 43(12 Pt 1):5783-8. PubMed ID: 6315216 [Abstract] [Full Text] [Related]
12. Transfer of delayed and Arthus sensitivity with blood plasma from x-irradiated guinea-pigs. Collins FM, Volkman A, McGregor DD. Immunology; 1970 Sep; 19(3):501-9. PubMed ID: 4248603 [Abstract] [Full Text] [Related]
16. [Immunology of tumors: cell mediated immune response of the host]. Lenzini L. Lotta Tuberc; 1969 Aug; 39(2):75-83. PubMed ID: 5280221 [No Abstract] [Full Text] [Related]
17. Transfer with a plasma fraction of delayed hypersensitivity to PPD in guinea pigs. Dupuy JM, Kalpaktosoglou P, Good RA. J Immunol; 1970 Jun; 104(6):1384-7. PubMed ID: 5419275 [No Abstract] [Full Text] [Related]
18. Delayed hypersensitivity and neoplasia: in vitro studies with macrophage migration. Steiner T, Watne AL. Cancer Res; 1970 Aug; 30(8):2265-70. PubMed ID: 5459770 [No Abstract] [Full Text] [Related]
19. Local lymphoid response as an index of tumor immunity. Fisher ER, Fisher B. Arch Pathol; 1972 Aug; 94(2):137-46. PubMed ID: 5046799 [No Abstract] [Full Text] [Related]
20. Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity. Shu S, Fonseca LS, Kato H, Zbar B. Cancer Res; 1983 Jun; 43(6):2637-43. PubMed ID: 6342756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]